Medical PCB Assembly

ISO 13485 Evidence

ISO 13485:2016 indicates to a purchaser that a vendor’s quality management system is oriented toward medical devices. The useful evidence is not in the certificate alone but in the vendor’s controlled operations, revision control, handling of nonconformances, build records, and traceability through a build batch.

When Does Class 3 Apply?

IPC-A-610J Class 3 documents acceptance criteria for electronic assemblies that must meet high reliability. IPC J-STD-001J defines solder materials and soldering requirements for manufacturing electronic assemblies. While both documents work together for procurement purposes and project criteria, they have different applications. Both belong on procurement drawings and project specifications.

A medical device monitoring accessory and a life-support control panel will have different consequences for a failure, and the difference belongs in the acceptance package: Class 3 criteria generally have tighter limits on solder fillets and voids, require additional test coupons for each lot, and require longer retention of inspection records. The manufacturer must connect those specific criteria to the actual device risk rather than generalize “medical” into one category.

Lot-Code Traceability

A quality team can use lot codes to trace component lots back to board serial numbers, build revisions, assembly batches, and inspection outputs. Barcodes linked to quality management system logs provide search capabilities to find those traceable connections. When boards are reworked or when components from different production lots are combined, the original lot traceability from the components to the boards may be lost unless the rework is documented back into the same lot chain.

This matters when a question involves only one component lot or production window. The quality team can narrow down the affected boards and review the specific inspection records instead of treating all boards as an undifferentiated group. Clear traceability is what the record needs to show; claiming “fully traceable” without clarity does not constitute traceability.

Component Spacing Risk

Spacing between components affects soldering profile control and the capacity for inspecting compact locations. If an object in the vicinity obstructs the sight line of a solder joint, this will hinder access to AOI and X-Ray. The spacing number is a marker for risk but does not represent the only layout rule. The limiting factors for placement of components on a circuit board include package height, pad shape, and density of other components near an area. Design reviews must identify locations where the density of components surrounding a joint will prevent effective validation of a solder joint through established AOI or X-Ray methods. High-power components may use thermal vias and 2 to 3 oz copper to move heat away from the components; the copper thermal mass and distribution for those areas will also influence the solder profile, and assembly must define where local heat control will occur before the final design is confirmed.

Sterilization-Compatible Materials

Material compatibility must be dictated by the appropriate cleaning or sterilization method, and the associated risk will typically be apparent after more than one cycle of cleaning or sterilization. For example, a steam cycle at 121°C generates repeated cycles of thermal and moisture stress to the laminate and solder mask materials; exposure to EtO results in the potential for absorption or off-gassing of chemicals in the laminate, solder mask, and flexible component structures, which have increased exposed surface area; and gamma exposure with accumulated dose during the life of a device can embrittle some polymers or coatings used on or in the device. Polyimide, PTFE, and RO4350B are available material choices, but no single material will provide a complete solution for every device’s reprocessing history. Material validation testing must validate to the number of reprocessing cycles expected for the device.

Test Access Before Production

All planned electrical tests and inspection methods will require a corresponding physical feature to be built into the PCB before assembly; these features cannot be added after the PCB has been manufactured.

Exposed test points let probes used for electrical testing connect to the circuit. Fiducials allow for accurate placement and inspection of the assembly, and BGA escape routes provide access and routing around component packages that are not directly visible.

One failure pattern is a PCB that lists ICT or flying probe testing as part of the test plan, and yet when it was laid out, the corresponding test points were not designed in. This gap in the PCB design is typically found at the NPI and not at the design review because the test points are difficult to see on the schematic but are very evident when the fixture for testing is first built. It is much more costly to close the gap after tooling has been built than it is to catch the error during DFM.

How Cleaning Affects Coating Risk

Coatings will not clean a PCB; they will seal in the cleanliness issues. If ionic residues below the conformal coating were not removed prior to the application of the coating, the ionic residue can create a delay in detecting failures: the accumulation of moisture under a pinhole or the separation of an unbonded edge will create a hidden reservoir where dendritic growth can continue without ever being seen by routine inspection. Cleaning and coating procedures need validation together, not separately.

Via-in-pad structures present a different but related risk. Insufficiently filled or poorly planarized via-in-pad structures can cause solder to escape during assembly, but due to the lack of visibility of the void during inspection, the issue may not be discovered until the electrical tests are performed. Traceability markings also need to be designed with the cleaned and coated PCBs in the same design run.

Which Supplier Evidence Matters?

In selecting a medical device PCB assembly manufacturer, the manufacturer must provide evidence demonstrating how ISO 13485:2016 controls are applied to the assembly record for that medical device. If the project specifies high-reliability requirements, the manufacturer shall also connect IPC-A-610J Class 3 acceptance to IPC J-STD-001J soldering controls. The focus is whether the records produced conform with the risk of the project.

The inspection evidence must be matched against the board risk and include 3D AOI, X-Ray/AXI, flying probe, ICT/TDR, and ROSE or ionic contamination data when applicable to the build. The construction of a PCB is a good indication of whether a supplier has the capabilities required to build the product being designed, but the supplier can still be missing some of the necessary handling or fabrication controls required to create a working PCB for the device being manufactured. Compare the actual built PCB with the layer count, layer thickness, trace spacing, and PCB type listed in the comparison table rather than a general supplier equipment list.

Also consider the supply chain behind the assembly line, and understand how deep the PCB supplier’s supply chain goes, because component support is easily promised to a customer, but when a component is out of stock, it can be very difficult for a PCB supplier to provide replacement components or requalify alternate parts when it is 2 weeks away from pilot build. PCB suppliers that are able to build a product from bare board fabrication through component qualification to assembly and box build typically have much greater flexibility when faced with component shortages, and normally can replace or requalify alternate sources for parts without having to go outside their own accountable supply chain.